MedPath

The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients

Not Applicable
Conditions
Lung Cancer
Registration Number
NCT00397124
Lead Sponsor
Rambam Health Care Campus
Brief Summary

the aim of this study is to measure brain metabolism in patients with lung cancer.FDG uptake in the brain in patients with malignant tumors will be compared to the amount of tracer activity found in patients who have benign pulmonary process. if differences between the brain uptake of FDG in the two groups will be found, further assessment will be performed in order to evaluate if such differences could be attributed and specifically localized to the brain regions innervated by the vagus

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • patients with SPN referred for routine whole body FDG-PET imaging
  • patients with NSCLC and patients with no evidence of lung cancer on further follow up
Exclusion Criteria
  • patients with a clinical history of vagotomy, abdominal surgery. brain tumor, brain trauma or CVA. or those with a systemic inflammatory disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
the impact of the imaging modality on patients management
Secondary Outcome Measures
NameTimeMethod
the impact of the imaging modality on patients management

Trial Locations

Locations (1)

Rambam Medical Center

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath